Mark Lubkeman was IntraBio’s Chief Operating Officer.  In that role, he was responsible for the planning and execution of our successful 2024 US AQNEURSA launch.  His responsibilities spanned across the Commercial and Operations value chain, including building our US team and guiding our ex-US team.
 
Before his role as COO, Mark was a Managing Director and Senior Partner at the Boston Consulting Group (BCG).  He has 25 years’ experience focused on the health care industry. He led BCG’s Global Biopharma business and spent his career in Los Angeles, Zurich and London working with the management teams of large, medium and earlier-stage biopharmas to accelerate growth and scale, leading a range of launch, transformation and M&A efforts.
 
Mark has a BA in Economics cum laude from Harvard University, and an MBA from the Harvard Graduate School of Business. Mark was also a Captain in US Army Military Intelligence and worked at another strategy consultancy.